Cabot (CBT) Research & Development (2009 - 2026)

Cabot (CBT) has reported Research & Development for 18 consecutive years, with $13.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 13.33% year-over-year to $13.0 million in Q2 2026; TTM through Jun 2026 was $55.0 million, a 9.84% decrease from a year earlier, with the FY2025 full-year figure at $59.0 million, down 6.35% from the prior year.
• Research & Development was $13.0 million for Q2 2026 at Cabot, down from $14.0 million in the prior quarter.
• Over five years, Research & Development peaked at $17.0 million in Q3 2024 and troughed at $13.0 million in Q4 2022.
• A 5-year average of $14.5 million and a median of $14.5 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development grew 21.43% in 2024 and fell 13.33% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $13.0 million in 2022, then grew by 15.38% to $15.0 million in 2023, then retreated by 6.67% to $14.0 million in 2024, then declined by 7.14% to $13.0 million in 2025, then changed by 0.0% to $13.0 million in 2026.
• The last three Research & Development figures came in at $13.0 million (Q2 2026), $14.0 million (Q1 2026), and $13.0 million (Q4 2025), per Business Quant data.